ERDEM, Hakan, A. INAN, E. GUVEN, S. HARGREAVES, L. LARSEN, G. SHEHATA, Eva PERNICOVÁ, E. KHAN, Lenka BAŠTÁKOVÁ, S. NAMANI, A. HARXHI, T. ROGANOVIC, B. LAKATOS, S. UYSAL, O. R. SIPAHI, A. CRISAN, E. MIFTODE, Roman STEBEL, B. JEGOROVIC, Z. FEHER, C. JEKKEL, N. PANDAK, A. MORAVVEJI, H. YILMAZ, A. KHALIFA, U. MUSABAK, S. YILMAZ, A. JOUHAR, N. OZTOPRAK, X. ARGEMI, M. BALDEYROU, G. BELLAUD, R. V. MOROTI, R. HASBUN, L. SALAZAR, R. TEKIN, A. CANESTRI, L. CALKIC, L. PRATICO, F. YILMAZ-KARADAG, L. SANTOS, A. PINTO, F. KAPTAN, P. BOSSI, J. ARON, A. DUISSENOVA, G. SHOPAYEVA, B. UTAGANOV, S. GRGIC, G. ERSOZ, A. K. L. WU, K. C. LUNG, A. BRUZSA, L. B. RADIC, H. KAHRAMAN, M. MOMEN-HERAVI, S. KULZHANOVA, F. RIGO, M. KONKAYEVA, Z. SMAGULOVA, T. TANG, P. CHAN, S. AHMETAGIC, H. POROBIC-JAHIC, F. MORADI, S. KAYA, Y. CAG, A. BOHR, C. ARTUK, I. CELIK, M. AMSILLI, H. C. GUL, A. CASCIO, M. LANZAFAME and M. NASSAR. The burden and epidemiology of community-acquired central nervous system infections: a multinational study. European Journal of Clinical Microbiology & Infectious Diseases. New York: Springer, 2017, vol. 36, No 9, p. 1595-1611. ISSN 0934-9723. Available from: https://dx.doi.org/10.1007/s10096-017-2973-0.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The burden and epidemiology of community-acquired central nervous system infections: a multinational study
Authors ERDEM, Hakan (792 Turkey), A. INAN (792 Turkey), E. GUVEN (792 Turkey), S. HARGREAVES (826 United Kingdom of Great Britain and Northern Ireland), L. LARSEN (208 Denmark), G. SHEHATA (818 Egypt), Eva PERNICOVÁ (203 Czech Republic), E. KHAN (586 Pakistan), Lenka BAŠTÁKOVÁ (703 Slovakia, guarantor, belonging to the institution), S. NAMANI (95 Republic of Kosovo), A. HARXHI (8 Albania), T. ROGANOVIC (70 Bosnia and Herzegovina), B. LAKATOS (348 Hungary), S. UYSAL (792 Turkey), O. R. SIPAHI (792 Turkey), A. CRISAN (642 Romania), E. MIFTODE (642 Romania), Roman STEBEL (203 Czech Republic, belonging to the institution), B. JEGOROVIC (688 Serbia), Z. FEHER (348 Hungary), C. JEKKEL (348 Hungary), N. PANDAK (191 Croatia), A. MORAVVEJI (364 Islamic Republic of Iran), H. YILMAZ (792 Turkey), A. KHALIFA (760 Syrian Arab Republic), U. MUSABAK (792 Turkey), S. YILMAZ (792 Turkey), A. JOUHAR (760 Syrian Arab Republic), N. OZTOPRAK (792 Turkey), X. ARGEMI (250 France), M. BALDEYROU (250 France), G. BELLAUD (250 France), R. V. MOROTI (642 Romania), R. HASBUN (840 United States of America), L. SALAZAR (840 United States of America), R. TEKIN (792 Turkey), A. CANESTRI (250 France), L. CALKIC (70 Bosnia and Herzegovina), L. PRATICO (380 Italy), F. YILMAZ-KARADAG (792 Turkey), L. SANTOS (620 Portugal), A. PINTO (620 Portugal), F. KAPTAN (792 Turkey), P. BOSSI (250 France), J. ARON (250 France), A. DUISSENOVA (398 Kazakhstan), G. SHOPAYEVA (398 Kazakhstan), B. UTAGANOV (398 Kazakhstan), S. GRGIC (70 Bosnia and Herzegovina), G. ERSOZ (792 Turkey), A. K. L. WU (156 China), K. C. LUNG (156 China), A. BRUZSA (348 Hungary), L. B. RADIC (191 Croatia), H. KAHRAMAN (792 Turkey), M. MOMEN-HERAVI (364 Islamic Republic of Iran), S. KULZHANOVA (398 Kazakhstan), F. RIGO (380 Italy), M. KONKAYEVA (398 Kazakhstan), Z. SMAGULOVA (398 Kazakhstan), T. TANG (156 China), P. CHAN (156 China), S. AHMETAGIC (70 Bosnia and Herzegovina), H. POROBIC-JAHIC (70 Bosnia and Herzegovina), F. MORADI (364 Islamic Republic of Iran), S. KAYA (792 Turkey), Y. CAG (792 Turkey), A. BOHR (208 Denmark), C. ARTUK (792 Turkey), I. CELIK (792 Turkey), M. AMSILLI (250 France), H. C. GUL (792 Turkey), A. CASCIO (380 Italy), M. LANZAFAME (380 Italy) and M. NASSAR (682 Saudi Arabia).
Edition European Journal of Clinical Microbiology & Infectious Diseases, New York, Springer, 2017, 0934-9723.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30303 Infectious Diseases
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.537
RIV identification code RIV/00216224:14110/17:00098556
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s10096-017-2973-0
UT WoS 000407582200010
Keywords in English Central nervous system infections; Epidemiology; Streptococcus pneumoniae; Neurosyphilis; Neuroborreliosis; CNS tuberculosis
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 21/3/2018 18:00.
Abstract
Risk assessment of central nervous system (CNS) infection patients is of key importance in predicting likely pathogens. However, data are lacking on the epidemiology globally. We performed a multicenter study to understand the burden of community-acquired CNS (CA-CNS) infections between 2012 and 2014. A total of 2583 patients with CA-CNS infections were included from 37 referral centers in 20 countries. Of these, 477 (18.5%) patients survived with sequelae and 227 (8.8%) died, and 1879 (72.7%) patients were discharged with complete cure. The most frequent infecting pathogens in this study were Streptococcus pneumoniae (n = 206, 8%) and Mycobacterium tuberculosis (n = 152, 5.9%). Varicella zoster virus and Listeria were other common pathogens in the elderly. Although staphylococci and Listeria resulted in frequent infections in immunocompromised patients, cryptococci were leading pathogens in human immunodeficiency virus (HIV)-positive individuals. Among the patients with any proven etiology, 96 (8.9%) patients presented with clinical features of a chronic CNS disease. Neurosyphilis, neurobrucellosis, neuroborreliosis, and CNS tuberculosis had a predilection to present chronic courses. Listeria monocytogenes, Staphylococcus aureus, M. tuberculosis, and S. pneumoniae were the most fatal forms, while sequelae were significantly higher for herpes simplex virus type 1 (p < 0.05 for all). Tackling the high burden of CNS infections globally can only be achieved with effective pneumococcal immunization and strategies to eliminate tuberculosis, and more must be done to improve diagnostic capacity.
PrintDisplayed: 28/7/2024 12:11